9th Annual Strategic Alliance Management Congress: Advancing Pharmaceuticals & Companion Diagnostics

Feb. 10, 2012 - PRLog -- Cambridge Healthtech Institute (CHI) announces the Ninth Annual Strategic Alliance Management Congress scheduled May 7-9, 2012. The theme to this year’s congress is Advancing Pharmaceuticals & Companion Diagnostics through Collaboration & Partnerships.  This event annually brings together alliance management, business development, technology transfer and licensing professionals to network and share experiences from their organizations. Visit http://www.healthtech.com/ams for conference and registration details including the recently completed final brochure pdf.

Working together in science is not a new idea, but pharmaceutical and companion diagnostic companies have developed novel strategies and tools for navigating and negotiating alliances.  Whether your organization is involved with another pharmaceutical, diagnostic company or an academic partner, you need the tools, methods and leadership skills to create a successful, harmonious relationship between your organizations.  

Join us in Philadelphia and hear presentations on useful renegotiation strategies.  If your organization is looking for, or is currently working with, Indian or Chinese partners, be sure not to miss the expert presentations on the challenges and rewards of creating alliances overseas.   Identify the key elements of an ailing alliance and the remedies that experts have used to save, renegotiate or end these projects. Discuss the best communication strategies for garnering leadership buy-in for alliance management resources.  Network with experts who have a wide range of expertise and experience.  Case studies from successful alliances will be presented throughout the program, complete with representatives from each party, discussing the art and science of managing their alliance.

Hear from these alliance professionals at this year's event:

Nick Dunscombe, Senior Executive Director, Head, Alliance Management, AstraZeneca - Keynote Presentation

Harm-Jan Borgeld, Ph.D., M.B.A., Head, Alliance Management, Merck Serono

Alessandro Foti, M.B.A., PMP, Director, Program Management, SpringLeaf Therapeutics, Inc

Stuart Kliman, Partner, Vantage Partners

Soren Bregenholt, Vice President & Head, Alliance Management, Novo Nordisk

Matthew J. Grove, M.B.A., Director, Deal Management, AstraZeneca

Angus Grant, Ph.D., Vice President, Global Alliances & Business Development, Celgene

Vipula Tailor, Ph.D., Director, Alliance Management, Corporate Strategy & Business Development, Vertex Pharmaceuticals, Inc.

Diana L. Brassard, Ph.D., Alliance Manager, Oncology, Sanofi Oncology

Andréa Nicholson, Director, Alliance Management, Merck Serono International

Teri Melese, Ph.D., Associate Professor, Medicine; Director, Research Technologies and Alliances, School of Medicine Dean's Office, University
California, San Francisco

Michal Preminger, Ph.D., M.B.A., Executive Director, Harvard Office of Technology Development

Preveen Ramamoorthy, Ph.D., Director, Molecular Diagnostics, Advanced Diagnostic Laboratories; Assistant Professor, Department of Medicine, National Jewish Health

Brent Zanke, M.D., CMO, Arctic Dx

Mark Coflin, M.B.A., Executive Director, Global Business Development & Licensing, Novartis Pharmaceuticals

Zafrira Avnur, Ph.D., Global Head, Academic Innovation Partnering, Roche Partnering, F. Hoffmann-La Roche Ltd

Steven M. Ferguson, CLP, Deputy Director, Licensing & Entrepreneurship, Office of Technology Transfer, National Institutes of Health

Daniel Victor, Esq., Founder, Victor Advisors PLLC

John Wilbanks, Senior Research Fellow, Ewing Marion Kauffman Foundation

Annlouise Goodermuth, MBA, CA-AM, Associate Director, Alliance Management Strategy, External Innovation and Science Policy, Sanofi

Seema Basu, Ph.D., Associate Director, Research Ventures & Licensing, Massachusetts General Hospital, Partners HealthCare

Frances Toneguzzo, Ph.D., Executive Director, Research Ventures and Licensing, Partners HealthCare

To inquire about sponsoring and/or exhibiting, contact Kaitlin Fitzgerald, 781-972-5458, kfitzgerald@healthtech.com.

Writers and editors are invited to attend.  To request a press pass, contact Tracey Fielding at tfielding@healthtech.com.

Visit http://www.healthtech.com/ams for conference and registration details including the recently completed final brochure pdf.

# # #

Since 1992, Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations.